HK

Haresh Kaluram Taware

Director DIN 02184617
DIN 02184617 First appointment Jun 2008
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Haresh Kaluram Taware

Data last updated:

Haresh Kaluram Taware was a Director at Angel Hospital & Criticare Private Limited (from 2011) and Director at Sudharshan Ispat Private Limited (from 2008).

DIN 02184617
First Appointment 05 Jun 2008
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 May 20112011Strike Off
Sudharshan Ispat Private Limited U27310MH2008PTC183218
Director05 Jun 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Angel Hospital & Criticare Private Limited
Sudharshan Ispat Private Limited
Premium access

Shareholding and investment profile for Haresh Kaluram Taware

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Haresh Kaluram Taware

Haresh Kaluram Taware was first appointed on 05 Jun 2008 as Director at Sudharshan Ispat Private Limited. The most recent appointment on record is 06 May 2011 at Angel Hospital & Criticare Private Limited.

Haresh Kaluram Taware held 2 earlier board appointments: Angel Hospital & Criticare Private Limited (Director, from 06 May 2011); Sudharshan Ispat Private Limited (Director, from 05 Jun 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available